Prof. Percy Knolle, director of the Institute of Molecular Immunology at TUM
Prof. Percy Knolle, director of the Institute of Molecular Immunology at TUM, speaks at the public Covid-19 Lectures on April 14.
Image: Andreas Heddergott / TUM
  • Covid-19, Event
  • Reading time: 2 MIN

Interview with Prof. Percy Knolle on his talk at the Covid-19 Lectures"The infection needs to be controlled at an early stage"

The Covid-19 Lectures, a public online lecture series in German language, open on April 14 at 6:15 p.m. with a talk by Prof. Percy Knolle. In this interview the director of the Institute of Molecular Immunology at TUM explains what consequences the excessive activation of the immune system by Covid-19 has for the body and what can be done about it.

How does the Human Body manage the Corona Virus?
The activation of the immune system is important so that we can control infectious agents and tumor cells. However, it is just as important to shut down the activated immune cells. This is because excessive activation of the immune system as in Covid-19 has many facets, such as the overproduction of antibodies and messenger substances that are particularly stimulating for further immune responses. These parameters can also be measured very well - there are probably other forms of excessive activation. 
Various organs are damaged, such as the lungs, heart, liver and brain. But above all also the vascular system. Damage to the vascular system in particular has the potential to cause severe disease progression.

What are the consequences?
Damage to the respective organs is sometimes difficult to repair. This in turn also means long courses of recovery. 

What can be done about it?
The infection needs to be controlled at an early stage, before Covid-19 develops - for example, through vaccination. Once Covid-19 has set in, we unfortunately still only have a few drugs that can prevent organ damage. Good experiences have been made so far with corticosteroids, which switch off all forms of the immune response. In addition, also with antibodies against certain messengers. 

Live stream „Wie schädigt das Immunsystem den Körper bei Covid-19?“ on April 14. 6:15 p.m.

Talk in German language


More information:

Technical University of Munich

Corporate Communications Center Corporate Communications Center

Article at

A multidimensional view of the coronavirus

What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of Biochemistry paints a...

COVID-19: Perspectives on current research

As the past year has shown, science is central to dealing with and combating the Corona pandemic. Researchers are constantly creating new knowledge about the virus, advising policymakers and industry on medical, ethical and...

Pollen counts increase the risk of developing covid-19.

Covid-19 risk increases with airborne pollen

When airborne pollen levels are higher, increased SARS-CoV-2 infection rates can be observed. These results were determined by a large-scale study conducted by an international team headed by researchers at the Technical...

Prof. Lothar H. Wieler, President of the Robert Koch Institute.

Munich Talk with the President of the Robert Koch Institute

The President of the Robert Koch Institute will speak at the Munich Talks, hosted by the Bavarian School of Public Policy (HfP) / TUM School of Governance, on March 11. Prof. Lothar H. Wieler will offer insights into the...

Ulrike Protzer is a Professor for Virology at TUM and spokesperson for the Bavarian alliance "FOR-COVID".

Covid-19: Insights into current research

The pandemic has shown how central science is for many areas of society: researchers are creating new knowledge about the virus, they are developing vaccines and treatment options, and they are advising politicians and...

Prof. Alena Buyx heads the Institute for the History and Ethics of Medicine at TUM and has been Chair of the German Ethics Council since Spring 2020.

Fair allocation in times of pandemic

At present Germany's elderly are being given priority for Covid-19 vaccination. But what happens when only minimal research data is available on the effects new vaccines have on the elderly? Such circumstances should play a...